Logos Global Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Logos Global Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,050,000	Closed	-$3.48M	–	80
2020 Q4	$3.48M	Sell	5,050,000 -450,000	-8%	-$959K	0.3%	44
2020 Q3	$12.4M	Buy	5,500,000 +1,500,000	+38%	+$4.28M	1.58%	18
2020 Q2	$14.3M	Buy	4,000,000 +2,724,500	+214%	+$9.83M	2.86%	17
2020 Q1	$4.85M	Sell	1,275,500 -2,047,316	-62%	-$6.74M	1.84%	20
2019 Q4	$10M	Buy	+3,322,816	New	+$8.64M	2.47%	17

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $77B AUM 10.33% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Logos Global Management's BMY.RT Position: Q1 2021 in Review

Logos Global Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 5,050,000 shares — an estimated $3.48M sold.

Logos Global Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $14.3M in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Logos Global Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Logos Global Management sold 5,050,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $3.48M.
Logos Global Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
Logos Global Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $14.3M in Q2 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Logos Global Management's 13F filing for Q1 2021, filed 17 May 2021.